Saiid Zarrabian
Founder chez Zarrabian Consulting
Profil
Saiid Zarrabian is the founder of Zarrabian Consulting, which was founded in 2002.
He holds the title of Principal at Zarrabian Consulting.
Mr. Zarrabian's former jobs include President, Chief Executive Officer & Director at Cyntellect, Inc. from 2010 to 2012, Chairman at La Jolla Pharmaceutical Co. from 2013 to 2015, Director-Research & Development at Computervision Corp., Director at Penwest Pharmaceuticals Co. in 2010, Director at Ambit Biosciences Corp.
from 2009 to 2012, Director & Head-Strategic Partnerships at Kintara Therapeutics, Inc. from 2017 to 2022, Director at Exemplar Pharma LLC, Director at Biostax Corp.
in 2015, Chief Operating Officer at Symbolics, Inc., President & Chief Operating Officer at Molecular Simulations, Inc., Principal at Invitrogen Corp., President & Chief Operating Officer at Senomyx, Inc., Chief Operating Officer at Pharmacopeia LLC, President-Protein Production Division & Senior VP at Precigen, Inc. from 2012 to 2013, Chief Operating Officer & Executive Consultant at SciTegic, Inc., Principal at BioBlocks, Inc., and Principal at eMolecules, Inc. from 2000 to 2012.
Postes actifs de Saiid Zarrabian
| Sociétés | Poste | Début |
|---|---|---|
| Zarrabian Consulting | Founder | 01/01/2002 |
Anciens postes connus de Saiid Zarrabian
| Sociétés | Poste | Fin |
|---|---|---|
| KINTARA THERAPEUTICS, INC. | Chief Executive Officer | 08/11/2021 |
| BIOSTAX CORP. | Director/Board Member | 29/12/2015 |
| PRECIGEN, INC. | Corporate Officer/Principal | 01/01/2013 |
| AMBIT BIOSCIENCES CORP | Director/Board Member | 19/12/2012 |
eMolecules, Inc.
 eMolecules, Inc. Internet Software/ServicesTechnology Services eMolecules, Inc. is a company that was founded in 2005 with the aim of reducing drug discovery timelines by improving the compound search and acquisition process. eMolecules is based in San Diego, CA, and has subsidiaries in the Netherlands and the United States. The company has created a powerful, reliable, and accurate digital chemical search engine that connects chemists to the world's largest readily available chemical space. eMolecules specializes in unique structures with dependable delivery options from a trusted network of hundreds of suppliers. The company has an extensive chemical database combined with industry-leading supply chain management, which enables the delivery of compounds quickly and reliably to chemists, allowing for the completion of more syntheses with more confidence and less time in the lab. The company was founded by Craig James and Klaus Gubernator, and the CEO is Niko Gubernator. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| KINTARA THERAPEUTICS, INC. | Health Technology |
| BIOSTAX CORP. | Health Technology |
| Entreprise privées | 15 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Computervision Corp.
 Computervision Corp. Packaged SoftwareTechnology Services Computervision Corporation is a private company that supplies electonic product definition solutions for company computer systems. The company is headquartered in Bedford, MA. | Technology Services |
Symbolics, Inc.
 Symbolics, Inc. Computer PeripheralsElectronic Technology Symbolics, Inc. manufactures artificial intelligence devices for computers. The private company is based in Burlington, MA. The company was founded by Dan Weinreb, Robert J. Werkmeister. The CEO is Bill Westerman. | Electronic Technology |
Molecular Simulations, Inc.
 Molecular Simulations, Inc. Packaged SoftwareTechnology Services Molecular Simulations, Inc. is a provider of predictive modeling software. The company is based in San Diego, CA and has subsidiaries in the United States. The company was founded by Stephen L. Mayo. Molecular Simulations was acquired by BIOVIA, Inc., part of Dassault Systèmes SA from April 30, 2014 on June 12, 1998 for $119.85 million. | Technology Services |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Invitrogen Corp.
 Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Electronic Technology |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Pharmacopeia LLC
 Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Cyntellect, Inc.
 Cyntellect, Inc. Miscellaneous Commercial ServicesCommercial Services Cyntellect, Inc. develops life science technologies. Its products supported key applications to advance life science research, biopharmaceutical production, and stem cell research and drug discovery. The company was founded by Paul R. Billings, Manfred R. Koller and Bernhard O. Palsson in 1997 and was headquartered in San Diego, CA. | Commercial Services |
SciTegic, Inc.
 SciTegic, Inc. Packaged SoftwareTechnology Services Part of Dassault Systèmes SA, SciTegic, Inc. designs, develops, and markets data analysis and mining software for the pharmaceutical and biotechnology sectors. The private company is based in San Diego, CA. The company was founded by Mathew A. Hahn. SciTegic was acquired by BIOVIA, Inc., part of Dassault Systèmes SA from April 30, 2014 on September 28, 2004 for $20.95 million. | Technology Services |
Exemplar Pharma LLC
 Exemplar Pharma LLC Medical SpecialtiesHealth Technology Part of AbbVie, Inc., Exemplar Pharma LLC is a private company that manufactures nasal and inhalation canisters. The company is based in Fall River, MA. Exemplar Pharma was acquired by Allergan, Inc., part of AbbVie, Inc. from June 15, 2015 on April 12, 2013 for $16.10 million. | Health Technology |
BioBlocks, Inc.
 BioBlocks, Inc. BiotechnologyHealth Technology Part of Genesis Biotechnology Group LLC, BioBlocks, Inc. is a collaborative medicinal chemistry research organization based in San Diego, CA. The private company focuses on drug discovery from initial hit through identification of development candidates. BioBlocks provides expertise and joins forces with its clients to discover compounds qualified for advancement to phase two clinical trials. Aided by a results-based lead optimization model, BioBlocks scientists have developed multiple preclinical candidates for its partners. The company's leap-to-lead platform provides an alternative source for high-quality tractable leads with multiple possible optimization pathways. The company was founded in 2002 by Peter Pallai, who has been the CEO since 2002. BioBlocks was acquired by Genesis Drug Discovery & Development LLC on October 07, 2021. | Health Technology |
eMolecules, Inc.
eMolecules, Inc. Internet Software/ServicesTechnology Services eMolecules, Inc. is a company that was founded in 2005 with the aim of reducing drug discovery timelines by improving the compound search and acquisition process. eMolecules is based in San Diego, CA, and has subsidiaries in the Netherlands and the United States. The company has created a powerful, reliable, and accurate digital chemical search engine that connects chemists to the world's largest readily available chemical space. eMolecules specializes in unique structures with dependable delivery options from a trusted network of hundreds of suppliers. The company has an extensive chemical database combined with industry-leading supply chain management, which enables the delivery of compounds quickly and reliably to chemists, allowing for the completion of more syntheses with more confidence and less time in the lab. The company was founded by Craig James and Klaus Gubernator, and the CEO is Niko Gubernator. | Technology Services |
| Zarrabian Consulting |
